The largest community of pharma leaders

Carbios Announces Strategic Alliance with the National Institute of Applied Sciences of Toulouse (INSA)

CLERMONT-FERRAND, France–()–Regulatory News:

CARBIOS (Paris:ALCRB) (Euronext Growth Paris: ALCRB), a French green chemistry company based in Clermont-Ferrand, announced today a strategic alliance with INSA Toulouse through the internationally recognized laboratory “Toulouse Biotechnology Institute”, a mixed research unit INSA Toulouse, INRA, CNRS.

Carbios is establishing, with TBI, a research center for enzymatic engineering, which will be focused on plastic recycling and biosynthesis. This laboratory, unprecedented in the world of enzymatic engineering and dedicated to plastic applications, will be inaugurated on January 28, 2020, at INSA Toulouse.

The cooperative laboratory, called “PoPLaB” (Plastic Polymers and Biotechnologies), is the culmination of seven years of scientific collaboration. This collective work led in 2016, to the creation of Carbiolice, Carbios’ subsidiary, dedicated to PLA biodegradation and in 2019, to the first 100% PET plastic bottles produced through Carbios’ biorecycling process.

Carbios also announced that it is becoming a member of the INSA Toulouse Foundation, an initiative that strengthens the links between the two entities. The Foundation makes a significant contribution to the training and international openness of students and scientific executives specifically with the creation of a program “Biotechnologies and Environment”.

Prof. Alain MARTY, Scientific Director of CARBIOS comments: “The creation of this laboratory represents several years of fruitful research devoted to the discovery and optimization of enzymes for the degradation and synthesis of polymers. This laboratory will benefit from state-of-the-art equipment in terms of enzyme modeling and understanding of plastic hydrolysis molecular mechanisms, high-throughput enzyme evolution platforms, all based on highly qualified researchers. This will enable us to take up new challenges by enlarging the range of polymers accessible to our enzymatic technology.”

Jean-Claude LUMARET, CEO of CARBIOS: “Carbios wishes to actively support the INSA Foundation because more than a vision, we share a common ambition: To contribute through innovation and research to a sustainable world that is respectful of our shared environment.”

Bertrand Raquet, Director of INSA Toulouse adds: “This is an exemplary partnership where an innovative company accelerates its technological research by establishing itself at the heart of our campus. The approach is twofold: together, we are creating a cooperative laboratory, by combining the expertise of Carbios, INSA, INRA, and CNRS for a new generation of plastics, degradable and recyclable. And together, we are developing the INSA model, with the support of the Foundation. Our engineering students and doctoral students, supported in their diversity, mobilize their expertise in biotechnologies and bioprocesses and engage in entrepreneurial approaches, for a sustainable world.”

About Carbios:

Carbios is a green chemistry company whose innovations meet the environmental and sustainable development challenges facing manufacturers. Since its creation in 2011 by Truffle Capital, the Company has developed, through biotechnology, two industrial processes that revolutionize the biodegradation and recycling of polymers. These innovations, a world first, optimize the performance and life cycle of plastics and textiles by exploiting the properties of highly specific enzymes.

Carbios’ economic development model is based on the industrialization and commercialization of its products and/or enzymes, technologies and bioprocesses through license concessions directly or through joint ventures to major industrial players or sectors concerned by the Company’s innovations. As such, Carbios created the joint venture Carbiolice in September 2016, in partnership with Limagrain Ingredients and the SPI fund operated by Bpifrance. This company, of which Carbios has majority control, will exploit the first technology licensed by Carbios by producing enzymatic granules to produce biodegradable and biobased plastics.

Carbios benefits from the qualification “Innovative Company” of Bpifrance allowing the eligibility of the Company’s securities for the investment of Mutual Funds Placement in Innovation (FCPI).For more information, please visit: www.carbios.fr

Carbios is eligible for the PEA-PME, a government program allowing French residents investing in SMEs to benefit from income tax rebates.

This press release does not constitute and cannot be regarded as constituting an offer to the public, an offer to sell or a subscription offer or as a solicitation to solicit a buy or sell order in any country.

Translation for information purposes only. In case of discrepancy between the French and the English version of this press release, the French version shall prevail.

Source

Recent Articles

Sperm Bank Market: COVID-19 Business Continuity Plan | Evolving Opportunities with Androcryos and Cryos International-Denmark ApS | Technavio

LONDON--(BUSINESS WIRE)-- #GlobalSpermBankMarket--The Global Sperm Bank Market will grow by $...

LEO Pharma Strengthens Global Leadership Team With Appointment of New Executive Vice President, Global Therapeutic & Value Strategy

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S today announced that Becki Morison will...

Creavo Medical Technologies Appoints Martin Frost as Chairman

COVENTRY, England--(BUSINESS WIRE)--Creavo Medical Technologies Ltd (Creavo), the medical device company...

Global Hereditary Transthyretin Amyloidosis (hATTR) Competitive Landscape, Market Insights, Epidemiology and Forecast 2017-2020 & 2030 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hereditary Transthyretin Amyloidosis (hATTR) - Competitive Landscape, Market Insights,...

Geneva Biotech Announces SARS-CoV-2 Antiviral Pipeline Based on Ground-Breaking Discovery Published in Science Magazine

GENEVA--(BUSINESS WIRE)-- #covid19--Geneva Biotech Announces SARS-CoV-2 Antiviral Pipeline Based on Ground-Breaking...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.